$TATT
TAT TECHNOLOGIES LTD Stock $tatt

$tatt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000117891324000845 Filed on March 06, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$31.84M	$113.8M	$22.85M
YoY Change	39.34%	34.58%	11.96%
Cost Of Revenue	$24.87M	$91.33M	$17.43M
YoY Change	42.65%	33.07%	-6.48%
Gross Profit	$6.969M	$22.47M	$5.416M
YoY Change	28.67%	41.06%	206.33%
Gross Profit Margin	21.89%	19.74%	23.7%
Selling, General & Admin	$4.822M	$16.11M	$4.094M
YoY Change	17.78%	3.28%	15.85%
% of Gross Profit	69.19%	71.71%	75.59%
Research & Development	$265.0K	$715.0K	$130.0K
YoY Change	103.85%	49.27%	-12.75%
% of Gross Profit	3.8%	3.18%	2.4%
Depreciation & Amortization	$1.670M	$4.710M	$876.0K
YoY Change	90.64%	27.09%	-32.82%
% of Gross Profit	23.96%	20.96%	16.17%
Operating Expenses	$5.132M	$16.39M	$4.224M
YoY Change	21.5%	-7.4%	31.38%
Operating Profit	$1.837M	$6.075M	$1.192M
YoY Change	54.11%	-442.25%	-182.38%
Interest Expense	-$549.0K	$1.683M	-$520.0K
YoY Change	5.58%	1225.2%	22.93%
% of Operating Profit	-29.89%	27.7%	-43.62%
Other Income/Expense, Net		$353.0K
YoY Change		-139.14%
Pretax Income	$1.288M	$4.672M	$630.0K
YoY Change	104.44%	-399.1%	-157.96%
Income Tax	$1.055M	$576.0K	$205.0K
% Of Pretax Income	81.91%	12.33%	32.54%
Net Earnings	$389.0K	$4.672M	$485.0K
YoY Change	-19.79%	-399.1%	-169.29%
Net Earnings / Revenue	1.22%	4.11%	2.12%
Basic Earnings Per Share		$0.52
Diluted Earnings Per Share	$0.04	$0.51	$0.05
COMMON SHARES
Basic Shares Outstanding	10.10M shares	8.962M shares	8.912M shares
Diluted Shares Outstanding		9.084M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.98M	$15.98M	$7.722M
YoY Change	106.93%	106.93%	-40.01%
Cash & Equivalents	$15.98M	$15.98M	$7.722M
Short-Term Investments
Other Short-Term Assets	$7.058M	$7.058M	$6.047M
YoY Change	16.72%	16.72%	43.33%
Inventory	$51.28M	$51.28M	$45.76M
Prepaid Expenses
Receivables	$20.01M	$20.01M	$15.62M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$94.33M	$94.33M	$75.15M
YoY Change	25.52%	25.52%	4.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.55M	$45.30M	$43.42M
YoY Change	-2.0%	-1.31%	29.33%
Goodwill
YoY Change
Intangibles	$1.823M		$1.623M
YoY Change	12.32%		-11.26%
Long-Term Investments	$2.168M	$2.168M	$1.665M
YoY Change	30.21%	30.21%	139.57%
Other Assets	$1.960M	$1.960M	$2.313M
YoY Change	-15.26%	-15.26%	-15.95%
Total Long-Term Assets	$51.25M	$51.25M	$51.50M
YoY Change	-0.49%	-0.49%	32.56%
TOTAL ASSETS
Total Short-Term Assets	$94.33M	$94.33M	$75.15M
Total Long-Term Assets	$51.25M	$51.25M	$51.50M
Total Assets	$145.6M	$145.6M	$126.7M
YoY Change	14.94%	14.94%	14.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.988M	$9.988M	$10.23M
YoY Change	-2.39%	-2.39%	12.54%
Accrued Expenses	$1.072M	$14.99M	$971.0K
YoY Change	10.4%	41.5%	-88.05%
Deferred Revenue	$5.239M		$2.778M
YoY Change	88.59%		142.2%
Short-Term Debt	$12.14M	$12.14M	$6.101M
YoY Change	98.95%	98.95%	1.55%
Long-Term Debt Due	$2.200M	$2.200M	$1.876M
YoY Change	17.27%	17.27%	171.49%
Total Short-Term Liabilities	$39.31M	$39.31M	$28.99M
YoY Change	35.6%	35.6%	17.96%
LONG-TERM LIABILITIES
Long-Term Debt	$12.89M	$12.89M	$19.41M
YoY Change	-33.6%	-33.6%	224.6%
Other Long-Term Liabilities	$2.697M	$2.697M	$2.683M
YoY Change	0.52%	0.52%	-23.19%
Total Long-Term Liabilities	$15.58M	$15.58M	$22.09M
YoY Change	-29.46%	-29.46%	133.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.31M	$39.31M	$28.99M
Total Long-Term Liabilities	$15.58M	$15.58M	$22.09M
Total Liabilities	$54.89M	$54.89M	$51.08M
YoY Change	7.46%	7.46%	50.02%
SHAREHOLDERS EQUITY
Retained Earnings	$13.27M		$8.597M
YoY Change	54.34%		-15.38%
Common Stock	$3.140M		$2.842M
YoY Change	10.49%		1.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.088M		$2.088M
YoY Change	0.0%		0.0%
Treasury Stock Shares			274.5K shares
Shareholders Equity	$90.68M	$90.68M	$75.57M
YoY Change
Total Liabilities & Shareholders Equity	$145.6M	$145.6M	$126.7M
YoY Change	14.94%	14.94%	14.27%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$389.0K	$4.672M	$485.0K
YoY Change	-19.79%	-399.1%	-169.29%
Depreciation, Depletion And Amortization	$1.670M	$4.710M	$876.0K
YoY Change	90.64%	27.09%	-32.82%
Cash From Operating Activities	$1.765M	$2.255M	$4.623M
YoY Change	-61.82%	-146.33%	360.0%
INVESTING ACTIVITIES
Capital Expenditures	$2.561M	$5.102M	$4.795M
YoY Change	-46.59%	-68.53%	-261.34%
Acquisitions
YoY Change
Other Investing Activities	$32.00K	$2.002M	$0.00
YoY Change		2052.69%	-100.0%
Cash From Investing Activities	-$2.529M	-$3.579M	-$4.795M
YoY Change	-47.26%	-77.8%	165.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$10.06M
YoY Change
Debt Paid & Issued, Net		$1.701M
YoY Change		58.82%
Cash From Financing Activities	10.13M	$10.24M	564.0K
YoY Change	1696.1%	-35.18%
NET CHANGE
Cash From Operating Activities	1.765M	2.255M	4.623M
Cash From Investing Activities	-2.529M	-$3.579M	-4.795M
Cash From Financing Activities	10.13M	$10.24M	564.0K
Net Change In Cash	9.366M	$8.916M	392.0K
YoY Change	2289.29%	-271.83%	-148.76%
FREE CASH FLOW
Cash From Operating Activities	$1.765M	$2.255M	$4.623M
Capital Expenditures	$2.561M	$5.102M	$4.795M
Free Cash Flow	-$796.0K	-$2.847M	-$172.0K
YoY Change	362.79%	-86.49%	-104.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2029-12-31
CY2023	dei	Entity Registrant Name EntityRegistrantName	TAT TECHNOLOGIES LTD
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Hamelacha 5
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Netanya
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	4250540
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, NIS 0.90 Par Value
CY2023	dei	Trading Symbol TradingSymbol	TATT
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1309
CY2023	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2023	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15979000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7722000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	345000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20009000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15622000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6047000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	45759000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	302000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	304000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2168000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1665000	usd
CY2023Q4	tatt	Severance Pay Fund SeverancePayFund	664000	usd
CY2022Q4	tatt	Severance Pay Fund SeverancePayFund	780000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	994000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1229000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42554000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43423000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2746000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2477000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1823000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1623000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	51251000	usd
CY2023Q4	us-gaap	Assets Assets	145577000	usd
CY2022Q4	us-gaap	Assets Assets	126651000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2200000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1876000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	12138000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6101000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9988000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10233000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	13952000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	9876000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1033000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	904000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39311000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28990000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12886000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19408000	usd
CY2023Q4	tatt	Severance Pay Liability SeverancePayLiability	1000000	usd
CY2022Q4	tatt	Severance Pay Liability SeverancePayLiability	1148000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1697000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1535000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15583000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22091000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	54894000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10377085	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9186019	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10102612	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8911546	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76335000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66245000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2088000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2088000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13269000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8597000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	90683000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	75570000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	145577000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126651000	usd
CY2023	us-gaap	Revenues Revenues	113794000	usd
CY2022	us-gaap	Revenues Revenues	84556000	usd
CY2021	us-gaap	Revenues Revenues	77973000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	91326000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	68628000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	66703000	usd
CY2023	us-gaap	Gross Profit GrossProfit	22468000	usd
CY2022	us-gaap	Gross Profit GrossProfit	15928000	usd
CY2021	us-gaap	Gross Profit GrossProfit	11270000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	715000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	479000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	517000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5523000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5629000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5147000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9970000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8354000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	433000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	90000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1715000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	16393000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17703000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	15305000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	6075000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1775000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4035000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4745000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1648000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4575000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	576000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-662000	usd
CY2023	tatt	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	4169000	usd
CY2022	tatt	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1746000	usd
CY2021	tatt	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3913000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	503000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	184000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-76000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	4672000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1562000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3989000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	427000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4672000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1562000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3562000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4672000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1562000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3562000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	53000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-89000	usd
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-76000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-30000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	19000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	53000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-59000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-95000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4725000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1621000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3657000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	80281000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3657000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76784000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1621000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	218000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	75570000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4725000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	165000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	159000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	90683000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4672000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1562000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3989000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3706000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4881000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	9000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-8000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	19000	usd
CY2023	tatt	Lease Modification LeaseModification	0	usd
CY2022	tatt	Lease Modification LeaseModification	0	usd
CY2021	tatt	Lease Modification LeaseModification	1315000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	-126000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	-467000	usd
CY2021	us-gaap	Restructuring Costs RestructuringCosts	657000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-182000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	138000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	248000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	503000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	184000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-76000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	159000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	218000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	160000	usd
CY2023	tatt	Accrued Severance Pay AccruedSeverancePay	148000	usd
CY2022	tatt	Accrued Severance Pay AccruedSeverancePay	356000	usd
CY2021	tatt	Accrued Severance Pay AccruedSeverancePay	-94000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1820000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	530000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	90000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	468000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	235000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	23000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-686000	usd
CY2023	tatt	Government Loan Forgiveness GovernmentLoanForgiveness	0	usd
CY2022	tatt	Government Loan Forgiveness GovernmentLoanForgiveness	0	usd
CY2021	tatt	Government Loan Forgiveness GovernmentLoanForgiveness	1442000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4205000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2934000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	341000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1836000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1035000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5069000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	681000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-245000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1143000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2571000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4202000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2727000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-218000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2255000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4867000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2269000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2002000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	93000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1163000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5102000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16213000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16247000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	479000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	555000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16120000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15639000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1701000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1071000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1000000	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	712000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	16680000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3042000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	165000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	189000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10240000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15798000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6042000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	777000	usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	777000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5189000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11089000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8026000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13215000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24304000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16942000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8026000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13215000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	196000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	199000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1345000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	318000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	399000	usd
CY2023	tatt	Noncash Or Part Noncash Capital Contribution To Equity Method Investee NoncashOrPartNoncashCapitalContributionToEquityMethodInvestee	0	usd
CY2022	tatt	Noncash Or Part Noncash Capital Contribution To Equity Method Investee NoncashOrPartNoncashCapitalContributionToEquityMethodInvestee	787000	usd
CY2021	tatt	Noncash Or Part Noncash Capital Contribution To Equity Method Investee NoncashOrPartNoncashCapitalContributionToEquityMethodInvestee	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1438000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	796000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	251000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div> <div> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1 -</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GENERAL</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAT Technologies Ltd., (“TAT” or the “Company”) an Israeli corporation, incorporated in 1985, is a leading provider of solutions and services to the aerospace and defense industries, focused mainly on the following four segments: (i) original equipment manufacturing (“OEM”) of heat transfer solutions and aviation accessories mainly through our Kiryat Gat facility and our Limco subsidiary; (ii) MRO (“Maintenance Repair and Overhaul”) services for heat transfer components and OEM of heat transfer solutions through Limco Airepair Inc our wholly-owned subsidiary; (iii) MRO services for aviation components (mainly Auxiliary Power Unit “APU” and Landing Gear “LG”) through Piedmont Aviation Component Services LLC our wholly-owned subsidiary; and (iv) overhaul and coating of jet engine components through Turbochrome our wholly-owned subsidiary. TAT targets the commercial aerospace (serving a wide range of types and sizes of commercial and business jets), military aerospace and ground defense sectors. TAT’s shares are listed on both the NASDAQ (TATT) and Tel-Aviv Stock Exchange.</span></span></div> <div><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2020, the Company<span style="font-weight:bold">'</span>s management decided to discontinue the JT8D engine blades reconditioning activity which belong to “overhaul and coating of jet engine components” segment as part of a strategic change, see Note 18.</span></span></div> <div> </div> </td> </tr> </table> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2021, the Company announced a restructuring plan which includes the transfer of the Company's activity of “OEM of heat transfer solutions and aviation accessories” in Gedera to our activity of “MRO services for heat transfer components and OEM of heat transfer solutions” in Tulsa, Oklahoma and to our “overhaul and coating of jet engine components” activity in Kiryat Gat, see Note 9.</span></span></div> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the years 2020 to 2022 the COVID-19 pandemic had an adverse effect on our industry and the markets in which we operate. The COVID-19 outbreak has significantly impacted the aviation market in which TAT’s customers operate and has resulted in a reduction of TAT’s business with some of these customers. Global supply shortages emerged for certain products, leading to delays in delivery schedule.</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, global conflicts continue to create volatility in global financial and energy markets and contribute to supply chain shortages adding to the inflationary pressures in the global economy. This capabilities lead to higher material and labor costs . The company actively collaborate with its suppliers to minimize impacts of supply shortages on manufacturing.</span></span></div> </td> </tr> </table> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. Since the commencement of hostilities, Tat technologies has experienced a considerable increased demand for our merchandise from the Israel Ministry Of Defense (IMOD) compared to the routine levels of demands, and we have increased our support to the IMOD, mainly through deliveries of our systems and dedicated efforts of our employees. Subject to further developments, this demand may continue and possibly generate material orders to the Company. At the same time, the Company continues to support its international customers. The extent of the effects of the war on the Company's performance will depend on future developments that are difficult to predict at this time, including the duration and scope of the war. We continue to monitor the situation closely Following the attack by Hamas on Israel’s southern border, Hezbollah in Lebanon has also launched missile, rocket, and shooting attacks against Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon.</span></span></div> </td> </tr> </table> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"> </div> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The intensity and duration of Israel’s current war against Hamas is difficult to predict, as are such war’s economic implications on our business and operations and on Israel's economy in general.</span></span></div> <div style="text-align:justify;line-height:1.25"> <div style="line-height:1.25"> </div> <div></div> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:18pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TAT has the following wholly owned subsidiaries: Limco-Piedmont Inc. (“Limco-Piedmont”), and Turbochrome Ltd. (“Turbochrome”). Additionally, the Company holds 51% of TAT-Engineering LLC (“TAT-Engineering”) as a joint venture, hereinafter collectively referred to as the “Group”.</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:74.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 25, 2015, the Company signed an agreement with Russian-based Engineering Holding of Moscow (“Engineering”), to establish a new facility for the provision of services for heat transfer products. The Company, TAT-Engineering LLC, is based in Novosibirsk’s Tolmachevo airport. TAT-Engineering, LLC shall provide services for heat transfer products. 51% of TAT-Engineering LLC's shares are held by TAT and the remaining 49% are held by Engineering. The accounting treatment of the joint venture is based on the equity method due to variable participating rights granted to Engineering. The new entity was established in January 2016.</span></span></div> </div> </div> </div> </div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:58.5pt"> </td> <td style="width:27pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates in the preparation of financial statement</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose the nature of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting years. Actual results could differ from those estimates.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As applicable to these financial statements, the most significant estimates and assumptions relate to: recoverability of inventory, provision for current expected credit loss, and income taxes.</span></span></div> </div>
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2746000	usd
CY2023Q4	tatt	Derivative Notional Amount Of Open Call Options DerivativeNotionalAmountOfOpenCallOptions	0	usd
CY2023Q4	tatt	Derivative Notional Amount Of Open Put Options DerivativeNotionalAmountOfOpenPutOptions	7774000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36934000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30410000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13493000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14525000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	853000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	824000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51280000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	45759000	usd
CY2022	tatt	Amount Of Rotables AmountOfRotables	8193000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	187000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1284000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	624000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	97922000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59432000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54499000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42554000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43423000	usd
CY2023	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	1800000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3300000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1173000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1316000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1640000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1316000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1345000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	318000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	904000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1535000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2730000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2439000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1056000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	810000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	385000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	281000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	472000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3004000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	274000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2730000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	279000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	279000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	190000	usd
CY2023Q4	tatt	Investment In Building And Infrastructures InvestmentInBuildingAndInfrastructures	0	usd
CY2022Q4	tatt	Investment In Building And Infrastructures InvestmentInBuildingAndInfrastructures	4571000	usd
CY2023Q4	tatt	Investment Amount In Machineries InvestmentAmountInMachineries	0	usd
CY2022Q4	tatt	Investment Amount In Machineries InvestmentAmountInMachineries	7799000	usd
CY2023Q4	tatt	Restructuring Items RestructuringItems	0	usd
CY2022Q4	tatt	Restructuring Items RestructuringItems	12560000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	975000	usd
CY2023	tatt	Restructuring Income From Lease Modification RestructuringIncomeFromLeaseModification	0	usd
CY2023	tatt	Restructuring Expenses From Assets Impairment RestructuringExpensesFromAssetsImpairment	0	usd
CY2022	tatt	Restructuring Expenses From Assets Impairment RestructuringExpensesFromAssetsImpairment	0	usd
CY2023	us-gaap	Other Restructuring Costs OtherRestructuringCosts	0	usd
CY2022	us-gaap	Other Restructuring Costs OtherRestructuringCosts	740000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023	tatt	Acceleration Of Assets Depreciation Expenses AccelerationOfAssetsDepreciationExpenses	0	usd
CY2022	tatt	Acceleration Of Assets Depreciation Expenses AccelerationOfAssetsDepreciationExpenses	0	usd
CY2023	tatt	Restructuring Charges One RestructuringChargesOne	0	usd
CY2022	tatt	Restructuring Charges One RestructuringChargesOne	1715000	usd
CY2023	tatt	Net Cash Used In Operating Activity For Restructuring Expenses NetCashUsedInOperatingActivityForRestructuringExpenses	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2146000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2277000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6299000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	15086000	usd
CY2023	tatt	Deduction From Payroll And Overhead Cost Of Revenues And Operating Expenses DeductionFromPayrollAndOverheadCostOfRevenuesAndOperatingExpenses	1200000	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	2000000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5179000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3951000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1072000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	971000	usd
CY2023Q4	tatt	Due To Government Authorities Current DueToGovernmentAuthoritiesCurrent	116000	usd
CY2022Q4	tatt	Due To Government Authorities Current DueToGovernmentAuthoritiesCurrent	200000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	325000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	243000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1736000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1448000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	222000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	95000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	13952000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	9876000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	170000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.56
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	590000	usd
CY2023	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	116000	usd
CY2022	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	274000	usd
CY2021	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	97000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	80000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	0	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	99000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	134000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	59000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	361000	usd
CY2022	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	412000	usd
CY2021	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	423000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	675000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	720000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.8
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	621460	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.26
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	190000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.52
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	178150	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.63
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	121460	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.9
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	43386	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.68
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	36850	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.25
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.31
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	675000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	720000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.8
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	373438	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.91
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	412813	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.54
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	379375	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.45
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.33
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.92
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4672000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1562000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3562000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8961689	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8874696	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	122333	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9084022	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8874696	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.175
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	625000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	675000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	720000	shares
CY2021	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	11000	usd
CY2021	tatt	Disposal Group Including Discontinued Operation Research And Development Net DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentNet	16000	usd
CY2021	tatt	Disposal Group Including Discontinued Operation Selling And Marketing DisposalGroupIncludingDiscontinuedOperationSellingAndMarketing	29000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	68000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	113000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-102000	usd
CY2021	tatt	Disposal Group Including Discontinued Operation Financial Expenses Income DisposalGroupIncludingDiscontinuedOperationFinancialExpensesIncome	0	usd
CY2021	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	529000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	427000	usd
CY2020Q4	tatt	Write Off Total Assets WriteOffTotalAssets	1400000	usd
CY2023	tatt	Preferred Income Tax Rate One PreferredIncomeTaxRateOne	0.06	pure
CY2023	tatt	Preferred Income Tax Rate Two PreferredIncomeTaxRateTwo	0.12	pure
CY2023	tatt	Domestic Maximum Tax Rate For Distributed Dividends From Preferred Income DomesticMaximumTaxRateForDistributedDividendsFromPreferredIncome	0.15	pure
CY2013Q3	tatt	Domestic Maximum Tax Rate For Distributed Dividends From Preferred Income DomesticMaximumTaxRateForDistributedDividendsFromPreferredIncome	0.20	pure
CY2014	tatt	Preferred Income Tax Rate One PreferredIncomeTaxRateOne	0.09	pure
CY2014	tatt	Preferred Income Tax Rate Two PreferredIncomeTaxRateTwo	0.16	pure
CY2017Q1	tatt	Uniform Tax Rate For Development Zone UniformTaxRateForDevelopmentZone	0.075	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1648000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4575000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023	tatt	Theoretical Tax Expense Benefit TheoreticalTaxExpenseBenefit	1091000	usd
CY2022	tatt	Theoretical Tax Expense Benefit TheoreticalTaxExpenseBenefit	-379000	usd
CY2021	tatt	Theoretical Tax Expense Benefit TheoreticalTaxExpenseBenefit	-1052000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-36000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-13000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	75000	usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-484000	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-48000	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	149000	usd
CY2022	tatt	Income Tax Reconciliation Change In Deferred Tax Assets From Discontinued Operation Loss IncomeTaxReconciliationChangeInDeferredTaxAssetsFromDiscontinuedOperationLoss	0	usd
CY2023	tatt	Reduced Deferred Tax Asset From Expecting Utilization Of Carryforward Losses ReducedDeferredTaxAssetFromExpectingUtilizationOfCarryforwardLosses	183000	usd
CY2022	tatt	Reduced Deferred Tax Asset From Expecting Utilization Of Carryforward Losses ReducedDeferredTaxAssetFromExpectingUtilizationOfCarryforwardLosses	0	usd
CY2021	tatt	Reduced Deferred Tax Asset From Expecting Utilization Of Carryforward Losses ReducedDeferredTaxAssetFromExpectingUtilizationOfCarryforwardLosses	0	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	59000	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	24000	usd
CY2023	tatt	Income Tax Reconciliation Temporary Differences For Which No Deferred Taxes Were Recorded IncomeTaxReconciliationTemporaryDifferencesForWhichNoDeferredTaxesWereRecorded	0	usd
CY2022	tatt	Income Tax Reconciliation Temporary Differences For Which No Deferred Taxes Were Recorded IncomeTaxReconciliationTemporaryDifferencesForWhichNoDeferredTaxesWereRecorded	238000	usd
CY2021	tatt	Income Tax Reconciliation Temporary Differences For Which No Deferred Taxes Were Recorded IncomeTaxReconciliationTemporaryDifferencesForWhichNoDeferredTaxesWereRecorded	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	77000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	71000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-178000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	164000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-27000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	576000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-662000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4639000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1201000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5139000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	106000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-447000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	564000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4745000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1648000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4575000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	49000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	358000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	268000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-579000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	169000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-111000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-107000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	576000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	157000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-686000	usd
CY2022	tatt	Previous Years Domestic Tax Expense Benefit PreviousYearsDomesticTaxExpenseBenefit	0	usd
CY2021	tatt	Previous Years Domestic Tax Expense Benefit PreviousYearsDomesticTaxExpenseBenefit	0	usd
CY2023	tatt	Previous Years Foreign Tax Expense Benefit PreviousYearsForeignTaxExpenseBenefit	0	usd
CY2022	tatt	Previous Years Foreign Tax Expense Benefit PreviousYearsForeignTaxExpenseBenefit	-59000	usd
CY2021	tatt	Previous Years Foreign Tax Expense Benefit PreviousYearsForeignTaxExpenseBenefit	24000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	576000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-662000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	657000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	378000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1337000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1288000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	956000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	2475000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2368000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4040000	usd
CY2023Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	417000	usd
CY2022Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	331000	usd
CY2023Q4	tatt	Deferred Income Tax Assets Gross DeferredIncomeTaxAssetsGross	5856000	usd
CY2022Q4	tatt	Deferred Income Tax Assets Gross DeferredIncomeTaxAssetsGross	8656000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5202000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2642000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1348000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1884000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	300000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	341000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1648000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2225000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	994000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1229000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5484000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5484000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-282000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5202000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1988000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3214000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	91326000	usd
CY2023	us-gaap	Gross Profit GrossProfit	22468000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	715000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5523000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10588000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	433000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	6075000	usd
CY2023	tatt	Financial Income Expenses Net FinancialIncomeExpensesNet	1330000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4745000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68628000	usd
CY2022	us-gaap	Gross Profit GrossProfit	15928000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	479000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5629000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9970000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	90000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1715000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1775000	usd
CY2022	tatt	Financial Income Expenses Net FinancialIncomeExpensesNet	-127000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1648000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	517000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5147000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8354000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	468000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4035000	usd
CY2021	tatt	Financial Income Expenses Net FinancialIncomeExpensesNet	-540000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4575000	usd
CY2023Q4	us-gaap	Assets Assets	145577000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4710000	usd
CY2023	tatt	Expenditure For Segment Assets ExpenditureForSegmentAssets	4390000	usd
CY2022Q4	us-gaap	Assets Assets	126651000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3706000	usd
CY2022	tatt	Expenditure For Segment Assets ExpenditureForSegmentAssets	17875000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	46571000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	51501000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	35405000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000808439
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-16050
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10102612	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	527000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	661000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6397000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51280000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	94326000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	75150000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	51501000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	51081000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.9	ils
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.9	ils
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3140000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2842000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	274473	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	274473	shares
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10588000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	468000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	1755000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1683000	usd
CY2022	us-gaap	Interest Expense InterestExpense	902000	usd
CY2021	us-gaap	Interest Expense InterestExpense	250000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	353000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1029000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-290000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.52
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.175
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.45
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.51
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.175
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.45
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.175
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.175
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.4
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8961689	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8911546	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8874696	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9084022	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8911546	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8874696	shares
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	189000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	141000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10064000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4710000	usd
CY2023	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	116000	usd
CY2022	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	377000	usd
CY2021	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	76000	usd
CY2023	tatt	Increase Decrease In Operating Right Of Use Asset And Operating Leasing Liability IncreaseDecreaseInOperatingRightOfUseAssetAndOperatingLeasingLiability	-22000	usd
CY2022	tatt	Increase Decrease In Operating Right Of Use Asset And Operating Leasing Liability IncreaseDecreaseInOperatingRightOfUseAssetAndOperatingLeasingLiability	82000	usd
CY2021	tatt	Increase Decrease In Operating Right Of Use Asset And Operating Leasing Liability IncreaseDecreaseInOperatingRightOfUseAssetAndOperatingLeasingLiability	73000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	172000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	902000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2659000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5400000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3579000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10064000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8916000	usd
CY2023	tatt	Relassification Inventory To Fixed Assets RelassificationInventoryToFixedAssets	68000	usd
CY2022	tatt	Relassification Inventory To Fixed Assets RelassificationInventoryToFixedAssets	284000	usd
CY2021	tatt	Relassification Inventory To Fixed Assets RelassificationInventoryToFixedAssets	829000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15979000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7722000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	661000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	302000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	304000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16942000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8026000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.9	ils
CY2023	tatt	Amount Of Rotables AmountOfRotables	10481000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	101986000	usd
CY2023	us-gaap	Depreciation Depreciation	4430000	usd
CY2022	us-gaap	Depreciation Depreciation	3500000	usd
CY2021	us-gaap	Depreciation Depreciation	4718000	usd
CY2023	us-gaap	Lease Income LeaseIncome	5500000	usd
CY2022	us-gaap	Lease Income LeaseIncome	4800000	usd
CY2021	us-gaap	Lease Income LeaseIncome	2700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2477000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1033000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1697000	usd
CY2022	tatt	Restructuring Income From Lease Modification RestructuringIncomeFromLeaseModification	0	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1715000	usd
CY2022	tatt	Net Cash Used In Operating Activity For Restructuring Expenses NetCashUsedInOperatingActivityForRestructuringExpenses	1700000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2164000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5239000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2778000	usd
CY2023Q4	tatt	Provision For Restructuring Plan ProvisionForRestructuringPlan	63000	usd
CY2022Q4	tatt	Provision For Restructuring Plan ProvisionForRestructuringPlan	190000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2778000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1147000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-2080000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-148000	usd
CY2023	tatt	Contract With Customer Liability Increase Decrease For Contract ContractWithCustomerLiabilityIncreaseDecreaseForContract	4541000	usd
CY2022	tatt	Contract With Customer Liability Increase Decrease For Contract ContractWithCustomerLiabilityIncreaseDecreaseForContract	1779000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5239000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2778000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	17000	usd
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	88000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	0	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	0	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	654000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	0	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	0	usd
CY2023	tatt	Schedule Of Fore Casted Severance Payments Due In Each Of Following Five Years ScheduleOfForeCastedSeverancePaymentsDueInEachOfFollowingFiveYears	<div> <div style="margin-left:54pt"> <div> <div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;color:rgb(0, 0, 0);width:60%"> <tr> <td style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);width:83%;vertical-align:bottom"> <div style="line-height:1.25"> <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"> <div style="line-height:1.25"> <div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amount</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:top;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;vertical-align:bottom"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2027</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;vertical-align:bottom"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2028</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"> <div style="line-height:1.25"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Thereafter (through 2032)</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"> <div style="line-height:1.25"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">349</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"> </td> </tr> <tr> <td style="vertical-align:top;width:83%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="line-height:1.25"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"> <div style="line-height:1.25"> <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">721</span></span></div> </div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"> </td> </tr> </table> </div> </div> </div> </div>
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	349000	usd
CY2023Q4	tatt	Defined Benefit Plan Aggregate Expected Future Benefit Payments DefinedBenefitPlanAggregateExpectedFutureBenefitPayments	721000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	625000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.31
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.63
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	220000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	196614	shares
CY2023	tatt	Options Exercised On Cashless Basis OptionsExercisedOnCashlessBasis	12500	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8911546	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8911546	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.175
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.4
CY2021	tatt	Account Receivable And Inventory Written Off AccountReceivableAndInventoryWrittenOff	529000	usd
CY2023Q4	tatt	Accumulated Tax Loss Carryforward From Israeli Subsidiary AccumulatedTaxLossCarryforwardFromIsraeliSubsidiary	2927000000	usd
CY2022Q4	tatt	Accumulated Tax Loss Carryforward From Israeli Subsidiary AccumulatedTaxLossCarryforwardFromIsraeliSubsidiary	3068000000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	138000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	970000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.80	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4745000	usd
CY2021	tatt	Income Tax Reconciliation Change In Deferred Tax Assets From Discontinued Operation Loss IncomeTaxReconciliationChangeInDeferredTaxAssetsFromDiscontinuedOperationLoss	-98000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	49000	usd
CY2023	tatt	Previous Years Domestic Tax Expense Benefit PreviousYearsDomesticTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	121000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	144000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3214000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3454000	usd
CY2023	tatt	Revenues External RevenuesExternal	113794000	usd
CY2023	tatt	Revenues Internal RevenuesInternal	0	usd
CY2022	tatt	Revenues External RevenuesExternal	84556000	usd
CY2022	tatt	Revenues Internal RevenuesInternal	0	usd
CY2021	tatt	Revenues External RevenuesExternal	77973000	usd
CY2021	tatt	Revenues Internal RevenuesInternal	0	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	66703000	usd
CY2021	us-gaap	Gross Profit GrossProfit	11270000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	1755000	usd

Files In Submission

Name	View Source	Status
0001178913-24-000845-index-headers.html	Edgar Link	pending
0001178913-24-000845-index.html	Edgar Link	pending
0001178913-24-000845.txt	Edgar Link	pending
0001178913-24-000845-xbrl.zip	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_13-2.htm	Edgar Link	pending
exhibit_14-1.htm	Edgar Link	pending
exhibit_8.htm	Edgar Link	pending
exhibit_97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
image00002.jpg	Edgar Link	pending
image1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tatt-20231231.xsd	Edgar Link	pending
zk2431093.htm	Edgar Link	pending
tatt-20231231_def.xml	Edgar Link	unprocessable
tatt-20231231_pre.xml	Edgar Link	unprocessable
tatt-20231231_lab.xml	Edgar Link	unprocessable
zk2431093_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tatt-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TATT
TAT TECHNOLOGIES LTD Stock $tatt

2023 Q4 Form 20-F Financial Statement

#000117891324000845 Filed on March 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TATT TAT TECHNOLOGIES LTD Stock $tatt

2023 Q4 Form 20-F Financial Statement

#000117891324000845 Filed on March 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TATT
TAT TECHNOLOGIES LTD Stock $tatt